RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
  NHS
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
British Medical Journal UK Channel

subscribe to UK newsletter
Healthcare : UK

   EMAIL   |   PRINT
UK in Grip of Nationwide Mumps Epidemic

May 13, 2005 - 5:25:00 PM
Both papers conclude that the current, two dose MMR schedule is effective in preventing mumps. They also suggest that no opportunity should be missed to offer MMR vaccine to the age group at highest risk, such as when entering school or university.

 
[RxPG] The United Kingdom is in the grip of a nationwide mumps epidemic, with almost 5,000 notifications in the first month of 2005 alone, show two papers in this week's BMJ.

The outbreaks are occurring predominantly in 19-23 year olds, but cases are also occurring in susceptible children, underlining the importance of ensuring that all children and young adults have had two doses of the MMR vaccine.

In the first paper (Savage et al), researchers from the Health Protection Agency report that in 2004, the number of mumps notifications in England and Wales increased to 16,436 from 4,204 in 2003. Most cases were in young adults born before 1988, who would not have been routinely scheduled for MMR during childhood.

The highest attack rate was in those born between 1983 and 1986, who were too old to be offered MMR vaccination routinely when it was introduced in 1988, although some may have received one dose of MMR as part of a catch-up programme at school entry.

In the second paper (Gupta et al), the authors suggest that cases in younger children may occur due to the recent fall in uptake of the MMR vaccine among 2 year olds - from around 92% in early 1995 to around 80% in 2003-4, and as low as 60% in some parts of London.

Both papers conclude that the current, two dose MMR schedule is effective in preventing mumps. They also suggest that no opportunity should be missed to offer MMR vaccine to the age group at highest risk, such as when entering school or university.



Publication: Read the full text of articles on the journal's web site (http://bmj.com)
On the web: Mumps outbreaks across England and Wales in 2004: observational study 

Advertise in this space for $10 per month. Contact us today.


Related UK News


Subscribe to UK Newsletter

Enter your email address:


 Additional information about the news article
Contacts:
(Mumps outbreaks across England and Wales in 2004: observational study)
http://bmj.com/cgi/content/full/330/7500/1119

(Clinical Review: Mumps and the UK epidemic 2005)
http://bmj.com/cgi/content/full/330/7500/1132

Paper 1: Health Protection Agency Press Office, Colindale, London, UK
Paper 2: Communications Department, Guy's and St Thomas' NHS Foundation Trust, London, UK
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)